youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/aboutus_seniormanagement.php
Why We Are Different. How to Contact Us. Why We Are Different. How to Contact Us. Peter Young, President and Managing Director. Stephen M. Floyd, Managing Director. Mr Floyd received an ScB in Chemical Engineering from Brown University and is a member of Tau Beta Pi. Randolph Guggenheimer III, Managing Director. Mr Guggenheimer has extensive M&A advisory experience in the biopharmaceutical, medical technology and diagnostics sectors. Prior to joining Young and Partners, Randy was a Managing Director ...
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/aboutus_whywearedifferent.php
Why We Are Different. How to Contact Us. Why We Are Different. Why We Are Different. How to Contact Us. In-depth knowledge of the chemical and life science industries and companies at all levels within the Firm, including knowledge of corporate strategies, management styles, and market dynamics. Timely communication of pertinent market trends and specific events to clients which may impact their operations or financial status. Focus on long-term relationships, not short-term fee maximization. Extensive c...
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/newsandarticles_2015.php
Why We Are Different. How to Contact Us. News and Articles - 2015. Banker - Chemicals M&A Market Steady in Third Quarter (Chemical Week Dec. 21 - 28, 2015 Issue) Chemical Week interviews Peter Young about trends and anomalies in the M&A, Equity and Debt Markets. Merger Would Lead to Split - Dow and DuPont (ICIS Chemical Business Dec 14 - 20, 2015 issue) Article about what to expect out of the merger and what the challenges will be to complete the deal. Contradictions in the Capital Markets (ICIS Nov 23 -...
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/newsandarticles_2012.php
Why We Are Different. How to Contact Us. News and Articles - 2012. Breaking Waves - Turbulent Times for the Biopharma Business (Young and Partners Article in Pharma Exec Nov 2012 Issue) Turbulence and Uncertainties Driving Pharma and Biotech M&A and Financial Environment. Banker - Big uptick in chemical debt financing (Chemical Week October 2, 2012) Peter Young comments on the strength of chemical industry debt and equity financing activity. Uncertain Outlook for Pharma and Biotech Deals Following 'Turbu...
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/newsandarticles_2010.php
Why We Are Different. How to Contact Us. News and Articles - 2010. Young and Partners Article on Improving Chemical Financing Markets in ICIS Chemical Business (December 10, 2010) Y&P article describing what is driving the recovery of the debt financing market, but the storm clouds that are appearing. Arizona Chemical Deal Press Release (November 19, 2010) Press release covering the completion of the Arizona Chemical transaction and Y&P s role as advisor to American Securities. Pharmaceutical Executive M...
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/conferences_lifescience.php
Why We Are Different. How to Contact Us. 2015 Speaker Summaries (178kb). 2014 Speaker Summaries (178kb). 2013 Speaker Summaries (347kb). 2012 Speaker Summaries (223kb). 2011 Speaker Summaries (263kb). 2010 Speaker Summaries (247kb). 2009 Speaker Summaries (269kb). 2008 Speaker Summaries (116kb). YOUNG and PARTNERS LLC 230 Park Avenue, Suite 1145, New York, NY 10169 212-682-5555.
youngandpartners.com
Young & Partners - Chemical and Life Sciences Investment Banking
http://www.youngandpartners.com/newsandarticles_2013.php
Why We Are Different. How to Contact Us. News and Articles - 2013. Pharma and Biotech Financial Trends: Every Which Way (Young and Partners article written for the Pharma Exec Dec 2013 Issue) Article summarizing the lastest business, M&A and financial developments in Biopharma. Activist Investors Target Chemicals (Young and Partners article in ICIS Oct. 1 - 13, 2013) Perspectives on what these activists try to do and how should management react?
konsulttorget.com
konsulttorget.com
http://www.konsulttorget.com/sida8.html
Nu är det jul igen. Denna sida kommer snart att vara uppdaterad med nyheter som ökar möjligheten för eget företagande och ger företag som söker konsulttjänster helt nya möjligheter att optimera köpet av konsulttjänster! 2008 Privacy Policy Terms of Use. Wwwriksdelen.se/company info.asp? Wwwavropa.nu/templates/ramavtalsomrade 810.aspx. Wwwavropa.nu/templates/rfqnotice 2339.aspx.
